| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | CONCERT PHARMACEUTICALS INCORPORATED | 66,968 | 677,000 | 0.47% | ||
| 52 | COGENTIX MED INC | 353,482 | 643,000 | 0.45% | ||
| 53 | Ascendis Pharma | 30,750 | 618,000 | 0.43% | ||
| 54 | SYNERON MEDICAL LTD | 85,947 | 615,000 | 0.43% | ||
| 55 | MASIMO CORP | 10,000 | 595,000 | 0.41% | ||
| 56 | INNOCOLL HLDGS PLC | 100,000 | 581,000 | 0.40% | ||
| 57 | ARRAY BIOPHARMA INC | 69,300 | 468,000 | 0.33% | ||
| 58 | MINERVA NEUROSCIENCES INC COM | 33,100 | 467,000 | 0.33% | ||
| 59 | Pieris Pharmaceuticals | 223,325 | 408,000 | 0.28% | ||
| 60 | BLUEBIRD BIO INC COM | 6,000 | 407,000 | 0.28% | ||
| 61 | IMMUNE DESIGN CORP | 40,000 | 303,000 | 0.21% | ||
| 62 | CELYAD SA | 12,528 | 296,000 | 0.21% | ||
| 63 | NEURODERM LTD | 14,421 | 267,000 | 0.19% | ||
| 64 | AQUINOX PHARMACEUTICALS INC | 20,000 | 267,000 | 0.19% | ||
| 65 | DEXTERA SURGICAL INC | 140,275 | 264,000 | 0.18% | ||
| 66 | NEOS THERAPEUTICS INC COM | 38,873 | 256,000 | 0.18% | ||
| 67 | PALATIN TECHNOLOGIES INC COM | 257,193 | 162,000 | 0.11% | ||
| 68 | AVINGER INC | 30,800 | 147,000 | 0.10% | ||
| 69 | Nivalis Therapeutics Inc | 15,000 | 122,000 | 0.08% | ||
| 70 | CATALYST | 70,903 | 86,000 | 0.06% | ||
| 71 | GENVEC INC | 95,800 | 45,000 | 0.03% | ||
| 72 | CEL SCI CORP | 127,482 | 39,000 | 0.03% | ||
| 73 | CHECK CAP LTD | 51,218 | 29,000 | 0.02% | ||
| 74 | ENTEROMEDICS INC | 33,334 | 5,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-16-000037, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
